NO120838B - - Google Patents
Download PDFInfo
- Publication number
- NO120838B NO120838B NO16927367A NO16927367A NO120838B NO 120838 B NO120838 B NO 120838B NO 16927367 A NO16927367 A NO 16927367A NO 16927367 A NO16927367 A NO 16927367A NO 120838 B NO120838 B NO 120838B
- Authority
- NO
- Norway
- Prior art keywords
- condensation
- phthalazones
- alkali
- general formula
- water
- Prior art date
Links
- 238000000034 method Methods 0.000 claims description 14
- 238000009833 condensation Methods 0.000 claims description 11
- 230000005494 condensation Effects 0.000 claims description 11
- 150000001408 amides Chemical class 0.000 claims description 8
- 150000003839 salts Chemical class 0.000 claims description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 6
- 229910052757 nitrogen Inorganic materials 0.000 claims description 3
- 125000001931 aliphatic group Chemical group 0.000 claims description 2
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- 125000000623 heterocyclic group Chemical group 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 150000003856 quaternary ammonium compounds Chemical class 0.000 claims description 2
- 125000003107 substituted aryl group Chemical group 0.000 claims 1
- 239000003513 alkali Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- 229910052783 alkali metal Inorganic materials 0.000 description 5
- 150000001340 alkali metals Chemical class 0.000 description 5
- 239000002585 base Substances 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- JUCCMEHWBGPJKS-UHFFFAOYSA-N 4-benzyl-2h-phthalazin-1-one Chemical compound C12=CC=CC=C2C(=O)NN=C1CC1=CC=CC=C1 JUCCMEHWBGPJKS-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- -1 dialkyl-aminoalkyl halides Chemical class 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000000155 melt Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000007795 chemical reaction product Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 239000003518 caustics Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 125000004985 dialkyl amino alkyl group Chemical group 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- 231100001261 hazardous Toxicity 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- IJAPPYDYQCXOEF-UHFFFAOYSA-N phthalazin-1(2H)-one Chemical compound C1=CC=C2C(=O)NN=CC2=C1 IJAPPYDYQCXOEF-UHFFFAOYSA-N 0.000 description 2
- FCMCDVRJVMDKAQ-UHFFFAOYSA-N 1-chloro-n,n-dimethylpropan-1-amine;hydrochloride Chemical compound Cl.CCC(Cl)N(C)C FCMCDVRJVMDKAQ-UHFFFAOYSA-N 0.000 description 1
- RAGSWDIQBBZLLL-UHFFFAOYSA-N 2-chloroethyl(diethyl)azanium;chloride Chemical compound Cl.CCN(CC)CCCl RAGSWDIQBBZLLL-UHFFFAOYSA-N 0.000 description 1
- LQLJZSJKRYTKTP-UHFFFAOYSA-N 2-dimethylaminoethyl chloride hydrochloride Chemical compound Cl.CN(C)CCCl LQLJZSJKRYTKTP-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 229910001854 alkali hydroxide Inorganic materials 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- 150000001414 amino alcohols Chemical class 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 239000007859 condensation product Substances 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000006471 dimerization reaction Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 125000000547 substituted alkyl group Chemical group 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/30—Phthalazines
- C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
Fremgangsmåte til fremstilling av ved amidnitrogenet basisk substituerte ftalazoner". Process for the preparation of phthalazones substituted basic at the amide nitrogen".
Oppfinnelsen vedrører en fremgangsmåte til fremstilling av ved amidnitrogenet basisk substituerte ftalazoner med den gene- . The invention relates to a method for the production of phthalazones substituted basic at the amide nitrogen with the gene- .
reile formel proper formula
hvori betyr en eventuelt i kjernen substituert aryl- eller wherein an optionally substituted in the nucleus means aryl or
aralkylrest, R2 betyr en toverdig rettlinjet eller forgrenet ali-fatisk kjede med 2 til 5 C-atomer, og R^og R^ betyr lavmolekylære aralkyl residue, R2 means a divalent straight or branched aliphatic chain of 2 to 5 C atoms, and R^ and R^ mean low molecular weight
alkylgrupper som også kan være sluttet til en heterocyklisk ring, samt deres salter og kvaternære ammoniumforbindelser ved kondensasjon av ftalazoner med den generelle formel med vannoppløselige salter av tertiære halogenalkylaminer eller deres hydrohalogenider med den generelle formel alkyl groups which may also be attached to a heterocyclic ring, as well as their salts and quaternary ammonium compounds by condensation of phthalazones of the general formula with water-soluble salts of tertiary haloalkylamines or their hydrohalides of the general formula
hvori Hal betyr halogen, og R1, R2>R-j og R^har den ovennevnte betydning, og fremgangsmåten erkarakterisert vedat man foretar kondensasjonen i nærvær av en konsentrert vandig oppløsning av^alkalihydroksyd i et molforhold på minst 4:1 ved temperaturer fra wherein Hal means halogen, and R1, R2>R-j and R^ have the above meaning, and the process is characterized by carrying out the condensation in the presence of a concentrated aqueous solution of ^alkali hydroxide in a molar ratio of at least 4:1 at temperatures from
50 til 60°C.50 to 60°C.
Forbindelser av denne type er verdifulle legemidlerCompounds of this type are valuable drugs
som utmerker seg ved histaminolytisk, spasmolytisk og lokalanestetisk virkning, spesielt har de en overordentlig sterk spesifikk og langvarig antihistaminvirkning. which are distinguished by their histamineolytic, spasmolytic and local anesthetic effects, in particular they have an extremely strong specific and long-lasting antihistamine effect.
Det er kjent (tysk patent nr. 1.046.625 ogIt is known (German patent no. 1,046,625 and
WP 17.075) at slike forbindelser kan fåes av i 4-stilling substituerte ftalazoner som 4-fenylftalazon, 4-benzylftalazon, idet disse sub-stituenter i kjernen likeledes kan være substituert ved kondensasjon med basisk substituerte alkylhalogenider i med vann ikke blandbare, tørre, upolare oppløsningsmidler som benzol, toluol eller xylol under anvendelse av ekvimolare mengder av et alkalimetall eller alkaliamider som kondensasjonsmiddel med oppløsningsmidlets koketemperatur. WP 17.075) that such compounds can be obtained from phthalazones substituted in the 4-position such as 4-phenylphthalazone, 4-benzylphthalazone, as these substituents in the core can also be substituted by condensation with basic substituted alkyl halides in water-immiscible, dry, non-polar solvents such as benzene, toluene or xylol using equimolar amounts of an alkali metal or alkali amides as a condensing agent with the boiling temperature of the solvent.
Det er videre kjent at man først kan overføre ftalazonet ved hjelp av vandig eller alkoholisk etsalkalier i dets alkalisalt; It is further known that one can first transfer the phthalazone by means of aqueous or alcoholic caustic alkali into its alkali salt;
dette må imidlertid deretter isoleres og tørkes før det for kondensasjon med basiske alkylhalogenider suspenderes i et av de nevnte oppløsningsmidler, da kondensasjonen i toluol under anvendelse av however, this must then be isolated and dried before it is suspended in one of the aforementioned solvents for condensation with basic alkyl halides, as the condensation in toluene using
alkalimetaller eller alkaliamider som kondensasjonsmidler krever fullstendig fravær av vann. Det er videre blitt foreslått å gjennom-føre kondensasjonen i absolutt alkohol med alkalialkoholat som kondensasjonsmiddel, idet det må anvendes forholdsvis store mengder absolutt alkohol som oppløsningsmiddel. alkali metals or alkali amides as condensing agents require the complete absence of water. It has also been proposed to carry out the condensation in absolute alcohol with alkali alcoholate as condensation agent, since relatively large amounts of absolute alcohol must be used as solvent.
De nevnte fremgangsmåter har den ulempe at de anvender brennbare organiske oppløsningsmidler som må opparbeides og anvendes vannfri, at de omfatter den ikke ufarlige håndtering av alkalimetaller eller alkaliamider, at de videre under tiden krever høyere temperaturer, lange reaksjonstider og en forholdsvis omstendelig opparbeidelse av reaksjonsprodukter. Dessuten støter deres overføring i teknisk målestokk på betraktelige vanskeligheter. The aforementioned methods have the disadvantage that they use flammable organic solvents that must be processed and used anhydrous, that they include the non-hazardous handling of alkali metals or alkali amides, that they also require higher temperatures, long reaction times and a relatively cumbersome processing of reaction products. Moreover, their transfer on a technical scale encounters considerable difficulties.
Oppfinnelsens forhold er å unngå de ved den tekniske innføring av fremgangsmåten funnede mangler, som unngåelse av fare-momentet og omgåelse av den omstendelige opparbeidelse av reaksjonsproduktet og det fremkommende oppløsningsmiddel. The purpose of the invention is to avoid the shortcomings found during the technical introduction of the method, such as avoiding the danger and bypassing the time-consuming work-up of the reaction product and the resulting solvent.
Til grunn for oppfinnelsen ligger derfor den oppgaveThe invention is therefore based on that task
å tilveiebringe en fremgangsmåte til fremstilling av nevnte forbindelser som ikke har de påviste ulemper. to provide a method for the production of said compounds which does not have the proven disadvantages.
Det ble overraskende funnet at man kan fremstille ved amidnitrogen basisk substituerte ftalazoner av den innledningsvis omtalte form på meget enkel måte ved svakt forhøyede temperaturer med minst like gode utbytter når mani-.under bestemte betingelser istedenfor organiske oppløsningsmidler anvender vann. Denne løsnings-måte kunne ikke forutsees da det er kjent at fri dialkylamino-alkylhalogenider slik de opptrer intermediært ved den nye fremgangsmåte, meget lett og hurtig dimeriserer i polare oppløsningsmidler, spesielt i vann, og derved unndrar seg den videre omsetning. Det var derfor ikke å vente at ved de anvendte reaksjonsbetingelser inntrer omtrent utelukkende kondensasjonen til de basiske substituerte ftalazoner og bireaksjoner ved dimerisering av dialkyl-aminoalkylhalogenidene unngås praktisk talt. Ifølge oppfinnelsen går det frem således at man sammenblander en konsentrert vandig opp-løsning av etsalkali under omrøring med ett i 4-stilling substituert ftalazon i molforhold på minst 4:1, oppvarmer bare litt og etter avslutning av oppvarmningen lar det renne til en konsentrert vandig oppløsning f.eks. av et dialkylaminoalkylkloridhydroklorid således at dennødvendige reaksjonstemperatur på 50-60°C opprettholdes av seg selv. Por å fullstendiggjøre reaksjonen etteromrøres det deretter ytterligere ca. 1 time ved 60°C. Den utkrystalliserte base kan etter avkjøling til værelsetemperatur på enkel måte isoleres ved frasugning av reaksjonsproduktet i utmerket utbytte på over 90% It was surprisingly found that basicly substituted phthalazones of the form mentioned at the outset can be prepared in a very simple manner at slightly elevated temperatures with at least as good yields when, under certain conditions, water is used instead of organic solvents. This method of solution could not be foreseen as it is known that free dialkylamino-alkyl halides, as they act as intermediates in the new process, dimerize very easily and quickly in polar solvents, especially in water, and thereby avoid further reaction. It was therefore not to be expected that, under the reaction conditions used, the condensation of the basic substituted phthalazones occurs almost exclusively and side reactions during dimerization of the dialkyl-aminoalkyl halides are practically avoided. According to the invention, the procedure is that a concentrated aqueous solution of caustic alkali is mixed together while stirring with a phthalazone substituted in the 4-position in a molar ratio of at least 4:1, heated only slightly and after the heating is finished, it is allowed to drain into a concentrated aqueous solution resolution e.g. of a dialkylaminoalkyl chloride hydrochloride so that the necessary reaction temperature of 50-60°C is maintained by itself. In order to complete the reaction, it is then stirred for approx. 1 hour at 60°C. The crystallized base can, after cooling to room temperature, be easily isolated by suctioning off the reaction product in an excellent yield of over 90%
av det teoretiske.of the theoretical.
I forhold til teknikkens stand har den nye fremgangsmåte en rekke fordeler. Det innspares organiske oppløsningsmidler og det unngås den ikke ufarlige håndtering av alkaliamider respektivt alkalimetaller. Videre fremkommer en energibesparelse. In relation to the state of the art, the new method has a number of advantages. Organic solvents are saved and the non-hazardous handling of alkali amides and alkali metals respectively is avoided. Furthermore, there is an energy saving.
En spesiell fordel er anvendelsesmuligheten av lett vannoppløselige salter av dialkylaminoalkylklorider f.eks. hydrokloridene slik de fremkommer ved fremstilling av de tilsvarende aminoalkoholer uten ytterligere opparbeidelse som dessuten i motsetning til de fri forbindelser praktisk talt er ugiftige og ubegrenset holdbare. Riktignok lar det seg f.eks. anvende et dialkylaminoalkylhalogenid også ved kondensasjonen i et vannfritt aromatisk hydrokarbon ved anvendelse av en tilsvarende ekstra mengde av alkaliamid eller alkalimetall som salt av halogenhydrogensyre}det kommer imidlertid ved denne fremgangsmåte etter tilsetning av salt av dialkylamino-alkylhalogenider ved oppvarmning til en teknisk vanskelig kontroller-bar spontan reaksjon, dessuten synker utbyttene ganske betraktelig, nemlig omtrent en tredjedel. Endelig kan det som videre fordel også fastslås en nedsettelse av arbeidstiden, da en rekke arbeidsprosesser kommer til bortfall ved den forenklede fremstillingsfremgangsmåte, f.eks. ved den enklere opparbeidelse av kondensasjonsproduktet såvel som ved bortfall av opparbeidelsen av oppløsningsmidlet. Fremgangsmåten lar seg også gjennomføre i teknisk målestokk uten vanskeligheter. A particular advantage is the possibility of using easily water-soluble salts of dialkylaminoalkyl chlorides, e.g. the hydrochlorides as they appear in the production of the corresponding amino alcohols without further processing which, moreover, in contrast to the free compounds, are practically non-toxic and have an unlimited shelf life. Admittedly, it is possible, e.g. using a dialkylaminoalkyl halide also by the condensation in an anhydrous aromatic hydrocarbon using a corresponding additional amount of alkali amide or alkali metal as a salt of hydrohalic acid} it comes, however, in this method after the addition of a salt of dialkylamino-alkyl halides by heating to a technically difficult controller-bar spontaneous reaction, moreover, the yields drop quite considerably, namely by about a third. Finally, as a further advantage, a reduction in working time can also be determined, as a number of work processes are eliminated by the simplified production method, e.g. by the simpler processing of the condensation product as well as by the omission of the processing of the solvent. The procedure can also be carried out on a technical scale without difficulty.
Utførelseseksempel:Execution example:
354 g 4-benzylftalazon innføres under omrøring i 750 ml 40$S-ig natronlut og oppvarmes deretter til 50°C. Etter å ha fjernet varmebadet lar man det hurtig renne til en tredjedel av en eventuelt filtrert oppløsning av 303 g teknisk dimetylaminoetylkloridhydroklorid i 150 ml vann under omrøring og resten tildryppes således at reaksjonstemperaturen'holder seg ved 60°C, hvilket krever ca. 20 minutter. Etter 15 minutter begynner basen å skille seg ut. Når temperaturen etter ca. 20 minutter begynner å falle, omrører man under varmetilførsel enda i 1 time ved 60°C, avkjøler til værelsetemperatur og fortynner med 300 ml vann. Man frasuger den utkrystalliserte base og vasker denne med vann på nutsch inntil vaskevannet er nøytralt. Den rå lysebrune fargede base tørkes ved 75°C. Utbyttet med vannoppløseligesalter av tertiære halogenalkylaminer eller deres hydrohalogenider med den generelle formel 354 g of 4-benzylphthalazone are introduced with stirring into 750 ml of 40% sodium hydroxide solution and then heated to 50°C. After removing the heating bath, one-third of an optionally filtered solution of 303 g of technical dimethylaminoethyl chloride hydrochloride in 150 ml of water is allowed to flow quickly while stirring and the remainder is added dropwise so that the reaction temperature remains at 60°C, which requires approx. 20 minutes. After 15 minutes, the base starts to separate. When the temperature after approx. 20 minutes begins to fall, stirring under heating for a further 1 hour at 60°C, cooling to room temperature and diluting with 300 ml of water. The crystallized base is suctioned off and this is washed with water on a Nutsch until the wash water is neutral. The raw light brown colored base is dried at 75°C. The yield with water-soluble salts of tertiary haloalkylamines or their hydrohalides of the general formula
hvori Hal betyr halogen, og R-^, R2> og R^har den ovennevnte betydning,karakterisert vedat man foretar kondensasjonen i nærvær av en konsentrert vandig oppløsning av alkalihydroksyd i et molforhold på minst 4:1 ved temperaturer fra 50 til 60°C. wherein Hal means halogen, and R-^, R2> and R^ have the above meaning, characterized by carrying out the condensation in the presence of a concentrated aqueous solution of alkali hydroxide in a molar ratio of at least 4:1 at temperatures from 50 to 60°C .
utgjør 420 g hvilket er 91, 2% av det teoretiske. Smeltepunktet ligger ved 105-106°C. Den rå base omkrystalliseres fra vandig aceton eller destilleres og hovedfraksjonen tas ved kokepunkt 0,1 208 til 210°C. Man får 406 g 2-($-dimetylaminoetyl)-4-benzylftalazon-(l) med smp. 107 til 108°C, hvis hydroklorid smelter ved 178°C. amounts to 420 g which is 91.2% of the theoretical. The melting point is at 105-106°C. The crude base is recrystallized from aqueous acetone or distilled and the main fraction taken at boiling point 0.1 208 to 210°C. 406 g of 2-($-dimethylaminoethyl)-4-benzylphthalazone-(1) with m.p. 107 to 108°C, the hydrochloride of which melts at 178°C.
På analog måte vil man av 4-benzylftalazon og dietyl-aminoetylkloridhydroklorid få 2-($-dietylaminoetyl)-4-benzylftalazon-(l) med kpQ 1 208 til 2l4°C, hydrokloridet smelter ved 142 til l43°C. In an analogous manner, from 4-benzylphthalazone and diethylaminoethyl chloride hydrochloride, 2-($-diethylaminoethyl)-4-benzylphthalazone-(1) with kpQ 1,208 to 214°C will be obtained, the hydrochloride melting at 142 to 143°C.
Fra 4-benzylftalazon og 1-dimetylaminopropylklorid-hydroklorid får man 2-(3-dimetylaminopropyl)-4-benzylftalazon-(l) med et kpQ 5 2l8°C, hvis hydroklorid smelter ved 173°C til 174°C. From 4-benzylphthalazone and 1-dimethylaminopropyl chloride hydrochloride one obtains 2-(3-dimethylaminopropyl)-4-benzylphthalazone-(1) with a kpQ 5 218°C, whose hydrochloride melts at 173°C to 174°C.
Analogt vil det av 4-p-klorbenzylftalazon og 3- dimetylaminoetylkloridhydroklorid dannes 2-(g-dimetylaminoetyl)-4- p-klorbenzylftålazon-(l) med et kpQ2215 til 220°C, hvis hydroklorid smelter ved 248°C og Analogously, 4-p-chlorobenzylphthalazone and 3-dimethylaminoethyl chloride hydrochloride form 2-(g-dimethylaminoethyl)-4-p-chlorobenzylphthalazone-(l) with a kpQ2215 at 220°C, whose hydrochloride melts at 248°C and
av 4-fenylftalazon og 3-dietylaminoetylkloridhydro-klorid får man 2-(B-dietylaminoetyl)-4-fenylftalazon-(l) med et kpQ 5 225 til 230°C, hvis hydroklorid smelter ved 198°C. of 4-phenylphthalazone and 3-diethylaminoethyl chloride hydrochloride gives 2-(B-diethylaminoethyl)-4-phenylphthalazone-(1) with a kpQ of 5 225 to 230°C, the hydrochloride of which melts at 198°C.
Claims (1)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DD12058666 | 1966-10-28 | ||
DEV0032947 | 1967-02-10 | ||
FR96957A FR1512879A (en) | 1966-10-28 | 1967-03-01 | Process for the manufacture of phthalazones with basic substituents |
Publications (1)
Publication Number | Publication Date |
---|---|
NO120838B true NO120838B (en) | 1970-12-14 |
Family
ID=27179690
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO16927367A NO120838B (en) | 1966-10-28 | 1967-08-05 |
Country Status (5)
Country | Link |
---|---|
BE (1) | BE697182A (en) |
CH (1) | CH491928A (en) |
DK (1) | DK119061B (en) |
FR (1) | FR1512879A (en) |
NO (1) | NO120838B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH572914A5 (en) * | 1971-01-22 | 1976-02-27 | Asta Werke Ag Chem Fab |
-
1967
- 1967-03-01 DK DK107667A patent/DK119061B/en unknown
- 1967-03-01 FR FR96957A patent/FR1512879A/en not_active Expired
- 1967-04-18 BE BE697182D patent/BE697182A/xx unknown
- 1967-08-05 NO NO16927367A patent/NO120838B/no unknown
- 1967-10-25 CH CH1489467A patent/CH491928A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
FR1512879A (en) | 1968-02-09 |
CH491928A (en) | 1970-06-15 |
BE697182A (en) | 1967-10-02 |
DK119061B (en) | 1970-11-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO169273B (en) | DOER MATH | |
US2233970A (en) | Quinoline compound and process of | |
SE425488B (en) | BENZOIC ACID DERIVATIVES INTENDED AS INTERMEDIATES FOR PREPARING AS DIURETIC USEFUL HETEROCYCLIC SUBSTITUTED 5-SULFAMOYLBENOIC ACID DERIVATIVES | |
NO175256B (en) | Analogous Process for Preparing Therapeutically Active 4-Oxoquinoline-3-Carboxylic Acid Derivatives | |
US2671805A (en) | Basically substituted o-arylamino-benzamides | |
NO120838B (en) | ||
US2652398A (en) | N-substituted-2-amino (methyl) quinolines | |
US1825623A (en) | Oonhohachzn | |
US2554737A (en) | Basically substituted tetrahydroquinoline derivatives | |
US2086822A (en) | Process for producing aromatic asymmetrical thiourea derivatives | |
CA1042899A (en) | Process for the preparation of furan compounds | |
US4774331A (en) | Process for ortho-cyanation of phenols or phenylamines | |
NO119231B (en) | ||
US2275354A (en) | Preparation of new therapeutically useful heterocyclic compounds | |
US4151210A (en) | Process for the production of phenylalkyl sulphones | |
US9062000B2 (en) | Bis-quinaldine compound and a process for preparing the same | |
US2187847A (en) | Condensation products of butyrolactones and primary amines of the aromatic and heterocyclic series | |
US2335221A (en) | Therapeutically useful heterocyclic compounds | |
Hovhannisyan et al. | Synthesis of new 3-cyanopyridine-2 (1H)-ones with unsaturated substituents at C-4 | |
Murray et al. | The Synthesis of Δ1-Pyrrolines1 | |
NO154131B (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CARBOSTYRIC DERIVATIVES. | |
US2559011A (en) | Manufacture of n-allyl derivatives | |
US2526232A (en) | Substituted hydantoins and methods for obtaining the same | |
US2554186A (en) | Para-amino hydroxybenzamides | |
US2030373A (en) | Derivatives of thiazole and process of preparing the same |